Patent and Trademark Office provides several clues to its purpose and mechanics: "Electrical crosstalk between two implantable
medical devices or two different therapy modules of a common implantable
medical device may be evaluated and, in some examples, mitigated.
Core was the active implantable
device manufacturing facility for Alfred Mann, and now will be controlled by Cirtec.
which makes insulin pumps and other products for diabetics, announced Wednesday that an affiliated company, Medical Research Group, has started human trials of a long-term implantable
The extraordinarily great potential benefit of a totally implantable
hearing aid for patients who suffer from hearing loss has been discussed in these pages before.
It was a moment of elation for everyone involved, but a particularly broad smile flashed across the face of cardiologist Michel Mirowski, who had invented the world's first implantable
defibrillator after a colleague suddenly dropped dead.
This book discusses the core technologies needed for implantable
sensor systems and their current and potential medical applications.
Contract notice: Pacemakers, implantable
defibrillators and implantable
As Cirtec continues to expand its business supporting the active implantable
market, the addition of Core's volume manufacturing will enable our customers to grow seamlessly with Cirtec from concept to market success," said Peter Howard, CEO of Cirtec Medical Systems.
The Implex TICA LZ 3001 is a totally implantable
electronic hearing device for the surgical treatment of selected patients who have moderate to severe high-frequency sensorineural hearing loss (SNHL).
ATLANTA -- Implantable
Provider Group (IPG) is pleased to announce a significant agreement with Blue Cross and Blue Shield of Florida, Inc.
Global Markets Direct's "Implantable
Cardioverter Defibrillator Clinical Trials Analysis" is an essential source of data and information pertaining to product clinical trials being carried out by Implantable
Cardioverter Defibrillator manufacturers, globally.
OTCBB:MIVT) (FWB:MIV), a leading developer of next-generation biocompatible coatings and advanced drug delivery systems for cardiovascular stents and other implantable
medical devices, announced that the Company has completed the acquisition of Biosync Scientific, an India-based designer and developer of innovative interventional cardiology products, including cardiovascular stents.